107: Divi’s Laboratories expansion plans raise hopes for its stock

Mark to Market

English - November 10, 2020 08:04 - 5 minutes - 5.16 MB
Business News News market price finance podcast investing stock market entrepreneurship business business podcast money market share market entrepreneur Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: 106: Gold loan lenders glitter, hope for growth to sustain

Next Episode: 108: IndiGo top aviation stock globally, as vaccine adds fuel to valuations

Divi’s Laboratories stock has gained a whopping 83%. The firm’s capital expenditure plans has cheered investors. Its September quarter results too support the boost to valuations of the stock.